Individualized approach to elexacaftor/tezacaftor/ivacaftor dosing in cystic fibrosis, in response to self-reported anxiety and neurocognitive adverse events: A case series

• Main Authors: Hisham Ibrahim (Author), Hammad Danish (Author), David Morrissey (Author), Kevin F. Deasy (Author), Mairead McCarthy (Author), James Dorgan (Author), Claire Fleming (Author), Ciara Howlett (Author), Sarah Twohig (Author), Tamara Vagg (Author), Desmond M. Murphy (Author), Michael Maher (Author), Barry J. Plant (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The prevalence of mental health disorders is high among people with Cystic Fibrosis. The psychological symptoms in CF are associated with poor adherence, worse treatment outcomes, and greater health utilization/cost. Mental health and neurocognitive Adverse Events (AEs) have been reported with all a...